Gujarat Themis Biosyn Overview
- Year Founded
-
1981
- Status
-
Public
- Employees
-
379
- Stock Symbol
-
506879
- Investments
-
2
- Share Price
-
$4.14
- (As of Thursday Closing)
Gujarat Themis Biosyn General Information
Description
Gujarat Themis Biosyn Ltd is engaged in the manufacturing and selling of bulk drugs on a job-work basis. The company operates in one segment, which is pharmaceuticals. Its products include Rifamycin-S, which is an intermediate for Rifampicin for the treatment of tuberculosis (TB), and Lovastatin. Geographically, the company derives the maximum revenue from India.
Contact Information
Website
www.gtbl.inCorporate Office
- 69/C GIDC Industrial Estate
- Valsad District
- Vapi, Gujarat 396195
- India
Corporate Office
- 69/C GIDC Industrial Estate
- Valsad District
- Vapi, Gujarat 396195
- India
Gujarat Themis Biosyn Stock Performance
As of 12-Nov-2026, Gujarat Themis Biosyn’s stock price is $4.14. Its current market cap is $539M with 130M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.14 | $4.15 | $2.38 - $5.12 | $539M | 130M | 21.3K | $0.05 |
Gujarat Themis Biosyn Financials Summary
As of 30-Jun-2026, Gujarat Themis Biosyn has a trailing 12-month revenue of $19.2M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 462,581 | 267,932 | 356,222 | 344,794 |
| Revenue | 19,173 | 18,764 | 17,833 | 20,512 |
| EBITDA | 9,346 | 8,780 | 8,363 | 9,604 |
| Net Income | 5,373 | 5,283 | 5,768 | 7,147 |
| Total Assets | 53,356 | 35,225 | 26,514 | |
| Total Debt | 0 | 17,150 | 3,562 | 332 |
Gujarat Themis Biosyn Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Gujarat Themis Biosyn Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Gujarat Themis Biosyn Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Gujarat Themis Biosyn Investments & Acquisitions (2)
Gujarat Themis Biosyn’s most recent deal was a Merger/Acquisition with MicroBiopharm Japan for . The deal was made on 18-Sep-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| MicroBiopharm Japan | 18-Sep-2026 | Merger/Acquisition | BPO/Outsource Services | ||
| Sanofi (Portfolio of Anti-Tuberculosis and Anti-Infective Generics in Mumbai, India) | 23-Apr-2026 | Corporate Asset Purchase | Buildings and Property |
Gujarat Themis Biosyn ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Gujarat Themis Biosyn Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| MicroBiopharm Japan | Tokyo, Japan | 2011 |
Gujarat Themis Biosyn FAQs
-
When was Gujarat Themis Biosyn founded?
Gujarat Themis Biosyn was founded in 1981.
-
Where is Gujarat Themis Biosyn headquartered?
Gujarat Themis Biosyn is headquartered in Vapi, India.
-
What is the size of Gujarat Themis Biosyn?
Gujarat Themis Biosyn has 379 total employees.
-
What industry is Gujarat Themis Biosyn in?
Gujarat Themis Biosyn’s primary industry is Pharmaceuticals.
-
Is Gujarat Themis Biosyn a private or public company?
Gujarat Themis Biosyn is a Public company.
-
What is Gujarat Themis Biosyn’s stock symbol?
The ticker symbol for Gujarat Themis Biosyn is 506879.
-
What is the current stock price of Gujarat Themis Biosyn?
As of 12-Nov-2026 the stock price of Gujarat Themis Biosyn is $4.14.
-
What is the current market cap of Gujarat Themis Biosyn?
The current market capitalization of Gujarat Themis Biosyn is $539M.
-
What is Gujarat Themis Biosyn’s current revenue?
The trailing twelve month revenue for Gujarat Themis Biosyn is $19.2M.
-
What is Gujarat Themis Biosyn’s annual earnings per share (EPS)?
Gujarat Themis Biosyn’s EPS for 12 months was $0.05.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
